Evercore ISI Group has downgraded DR Horton Inc (DHI) to In-Line from Outperform, signaling increased caution regarding the company's outlook. The action, effective October 6, 2025, comes as DR Horton faces potential competitive pressures and market conditions that may impact its performance.
Currently priced at $145.47, DR Horton operates in the consumer products sector, specifically in homebuilding. The company constructs and sells single-family homes across 125 markets in 36 states, employing 14,766 full-time staff. It also has segments in rental operations, residential lot development, and financial services, providing mortgage financing and title agency services.
As of November 20, 2025, DR Horton holds a market cap of $40.8 billion, with a P/E ratio of 11.39 and an EPS of 11.60. The company has a dividend yield of 130.9%. Upcoming earnings reports are scheduled for July 20, 2026, with an estimated EPS of $3.40 and revenue of $9.8 billion, and April 21, 2026, with an estimated EPS of $2.54 and revenue of $7.9 billion.
This downgrade highlights the importance of monitoring analyst ratings, which can change based on evolving market information. Investors should consider a range of factors, including company fundamentals and industry trends, when making decisions.